A Phase 2 study of Ad-RTS-hIL-12 plus veledimex in combination with Libtayo (cemiplimab-rwlc) in patients with rGBM
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2019
At a glance
- Drugs Cemiplimab (Primary) ; INXN 2001 (Primary) ; Veledimex (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 11 Feb 2019 According to a ZIOPHARM Oncology media release, this trial is expected to begin in the second quarter of 2019.
- 28 Nov 2018 New trial record
- 12 Nov 2018 According to a ZIOPHARM Oncology media release, the company will initiate the trial in the first half of 2019.